Tsc2+/- mice are useful in studying Tuberous sclerosis. In addition, the mTOR hyperactivation exhibited by Tsc2+/- mice causes impaired basal neuronal autophagy, resulting in autism spectrum disorder (ASD)-like basal dendritic spine pathology and social recognition/interaction deficits.
David J. Kwiatkowski, Brigham and Women's Hospital
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Null/Knockout) | Tsc2 | tuberous sclerosis 2 |
Exon 2 of the tuberous sclerosis 2 gene (Tsc2) has been replaced by a neo cassette, abolishing gene expression. TSC2 is a putative tumor supressor. Mutation of TSC2 have been associated with the onset of tuberous sclerosis complex (TSC) which is characterized by the formation of non-malignant tumors in many different organs. Heterozygous (Tsc2+/-) mice are viable and fertile. Homozygous (Tsc2-/-) mice have an embryonic lethal phenotype, failing to develop past embryonic days 9.5 to 12.5 due to hepatic hypoplasia. Cultured neuroepithelial progenitor cells isolated from embryonic day 10.5 embryos display abnormal growth and differentiation. All heterozygotes develop multiple bilateral renal cystadenomas by 12-15 months of age. By 15 months, about half develop liver hemangiomas (more common in females than in males). Less than 10% develop extremity angiosarcomas or renal carcinoma. Little or no gene product (protein) is detected by Western blot in renal cystadenomas. PCR analysis reveals loss of the wildtype allele in about 30% of lesions. Phenotype variability is dependent on genetic background.
Tsc2 haploinsufficiency causes mTOR hyperactivation: the subsequent autophagy inhibition results in autism spectrum disorder (ASD)-like basal dendritic spine pathology and social recognition/interaction deficits. Rapamycin treatment rescues the dendritic spine pruning defect and social abnormalities. Tsc2+/- mice do not exhibit stereotyped/repetitive behavior, motor defects or anxiety-like behavior.
A targeting vector containing neomycin resistance and herpes simplex virus thymidine kinase genes was used to disrupt exon 2 of the tuberous sclerosis 2 locus on chromosome 17. The construct was electroporated into 129S4/SvJae-derived J1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric animals were crossed to C57BL/6 mice. Heterozygotes were then intercrossed.
Allele Name | targeted mutation 1, David J Kwiatkowski |
---|---|
Allele Type | Targeted (Null/Knockout) |
Allele Synonym(s) | Tsc-; Tsc2- |
Gene Symbol and Name | Tsc2, tuberous sclerosis 2 |
Gene Synonym(s) | |
Strain of Origin | 129S4/SvJae |
Chromosome | 17 |
Molecular Note | A neomycin cassette was inserted into the second coding exon of the gene. |
Mutations Made By | David Kwiatkowski, Brigham and Women's Hospital |
When maintaining a live colony, heterozygous mice may be bred together or to wildtype mice from the colony. Homozygotes have an embryonic lethal phenotype. The expected coat color is Black.
When using the B6;129S4-Tsc2tm1Djk/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #004686 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Tsc2<tm1Djk> |
Frozen Mouse Embryo | B6;129S4-Tsc2<tm1Djk>/J Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | B6;129S4-Tsc2<tm1Djk>/J Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | B6;129S4-Tsc2<tm1Djk>/J Frozen Embryos | $3373.50 |
Frozen Mouse Embryo | B6;129S4-Tsc2<tm1Djk>/J Frozen Embryos | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.